Effects of three H2-receptor antagonists (cimetidine, famotidine, ran0itidine) on serum gastrin level

International Journal of Clinical Pharmacology Research

Volumn 22, Issue 2, 2002, Pages 29-35

  Ohsawa, T ^a   Hirata, W ^b   Higichi, S ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Chidoribashi Byoin   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; ANTIULCER AGENT; HISTAMINE H2 RECEPTOR;

ADULT; AGED; ARTICLE; DIET RESTRICTION; DRUG EFFECT; DUODENUM ULCER; FEMALE; GASTRIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAL; STOMACH ULCER; AREA UNDER THE CURVE; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PHYSIOLOGY;

ADULT; ANTI-ULCER AGENTS; AREA UNDER CURVE; CIMETIDINE; DUODENAL ULCER; FAMOTIDINE; FEMALE; GASTRINS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANITIDINE; RECEPTORS, HISTAMINE H2; STATISTICS, NONPARAMETRIC; STOMACH ULCER;

EID: 0036455561     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tomoji O., Keisou M., Wataru H. Reversal of ranitidine-induced hypergastrinemia by cimetidine. Ann. Pharmacother., 28, 1303, 1994.
2. Ohsawa T, Hirata T, Konishi K. Study of cimetidine therapy in peptic ulcer patients. Clin. Pharm. (Jpn), 7, 116, 1985.
3. 2-receptor antagonists. Jpn. J. Clin. Pharmacol. Ther., 20, 247, 1989.
4. Joseph C.C. Ranitidine hydrochloride-induced hypergastrinemia. J. Nat. Med. Assoc., 77 (4), 303, 1985.
5. Lombardo L., Babahdo G.M., De La Pierre M., et al. Long- term ranitidine treatment for the maintenance of duodenal ulcer healing. Int. J. Tissue React., 5 (3), 323, 1983.
6. Takemoto T, Okazaki Y, Namiki M., et al. Double blind study of ranitidine in gastric ulcer. J. Adult Disease (Jpn), 13, 123, 1983.
7. Takemoto T., Okazaki Y., Namiki M., et al. Double blind study of ranitidine in duodenal ulcer. J. Adult Disease (Jpn), 13, 335, 1983.
8. Takemoto T., Okazaki Y., Namiki M., et al. Open multi-center clinical trial of ranitidine in gastric and duodenal ulcer. J. Adult Disease (Jpn), 12, 899, 1982.
9. 2 antagonists. J. Clin. Gastroenterol., 13, 284, 1991.
10. Pensston J.G., Dixon J.S., Selway S.A.M., Wormselery K.G. Gastric histology and plasma response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine: Aliment. Pharmacol. Therap., 4, 381, 1990.
11. Ohsawa T., Mastuura M., Tomimastu M., et al. Change of gastrin with cimetidine, ranitidine and famotidine. Jpn. J. Clin. Pharmacol. Ther., 19, 255, 1988.
12. Yashida Y., Sakai H., Kasano T., Hirose K., Kimura K. Change of gastrin in gastric ulcer with ranitidine treatment. Jpn. J. Gastroenterol., 83, 33, 1986.
13. Shiratori K., Watanabe S., Maruyama M., et al. Change of gastric acid, secretin and gastrin in duodenal ulcer with famotidine. Jpn. J. Gastroenterol., 81, 855, 1984.
14. Havu N., Mattssson H., Carisson K., Lundell L., Carisson E. Partial fundectomy results in hypergastrinemia and the development of gastric ECL cell carcinoids in the rats. Scand. J. Gastroenterol., 24 (Suppl. 166), 158, 1989.
15. Elly C., Klinknberg K., Frits N., et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety and influence on gastric mucosa. Gastroenterology, 118, 661, 2000.
16. Bengt H., Peter U., Lasse C., et al. Omeprazole or ranitidine in long-treatment of reflux esophagitis. Gastroenterology, 107, 1305, 1994.
17. Marie-Daniele D., Sylvia R., Alan D., et al. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drug and controls. Dig. Dis. Sci., 8, 1629, 1998.
18. Endou M., Sugihara K. Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI. Nihon Rinsho (Jpn), 58, 1865, 2000.
19. 2 receptor antagonist resistant reflux esophagitis. Rinsho Iyaku (Jpn), 16, 1387, 2000.
20. Yakita M., Nagamatu U., Miura R., Ohe K., Taoka K. Influence of gastrin secretion. Rinsho to Kenkyu (Jpn), 64, 3194, 1987.
21. Nishi S., Kiyono K. Auto-regulation mechanism of gastrin. In: Ohe K., Hayakawa A. (Eds.). "Mechanism of Gastric Acid Secretion and Gastric Parietal Cell Receptor Antagonist". Toyoshoten, Tokyo, 1986, pp. 102.
22. 2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin and gastric emptying in patient with duodenal ulcer. Gastroenterology, 71, 19, 1976.
23. 2-receptor antagonist. In: Ohe K., Hayakawa A. (Eds.). "Mechanism of Gastric Acid Secretion and Gastric Parietal Cell Receptor Antagonist". Toyoshoten, Tokyo, 1986, 303.
24. 3H-cimetidine binding and histamine stimulated c-AMP production in isolated gastric glands from guinea pig stomach. Jpn. J. Clin. Exptl. Med., 130, 433, 1984.